Serono spin­out grabs a $31M round for a pair of proof-of-con­cept Parkin­son’s tri­als

Near­ly 5 years ago, Prex­ton Ther­a­peu­tics was the first new biotech to be spun out of the wreck­age left be­hind af­ter Mer­ck KGaA de­cid­ed to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.